Clarivate Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Clarivate yıllık ortalama 18.4% oranında kazançlarını artırırken, Professional Services sektöründe kazançlar growing at 9.6% annual. Gelirler yılda ortalama 4.7% oranında büyüyor .
Anahtar bilgiler
18.44%
Kazanç büyüme oranı
18.98%
EPS büyüme oranı
| Professional Services Sektör Büyümesi | 10.99% |
| Gelir büyüme oranı | 4.67% |
| Özkaynak getirisi | -7.36% |
| Net Marj | -13.84% |
| Son Kazanç Güncellemesi | 30 Jun 2026 |
Yakın geçmiş performans güncellemeleri
Recent updates
Anlatı Güncellemesi • Sep 03
CLVT: Rebuilding Effort And AI Expansion May Support Future Cash Flow
Clarivate’s analyst price target has been revised from $2.50 to $2.00, with analysts citing an extended timeline for the company’s effort to rebuild its foundations as the primary reason for the change. Analyst Commentary Recent commentary on Clarivate focuses on how much time it may take for the company to rebuild its foundations and what that could mean for the stock’s valuation and execution risk.
Anlatı Güncellemesi • Aug 14
CLVT: AI Platforms And Rebuilding Efforts Will Support Future Upside
Analysts have lowered their implied fair value for Clarivate from $6.00 to about $5.32, reflecting recent cuts in Street price targets from $2.50 to $2.00 as some see the company’s foundation rebuilding efforts taking longer to play out. Analyst Commentary Recent research on Clarivate highlights mixed views, with some analysts focusing on the time needed for the company to rebuild its foundations and others flagging areas where execution could support a more constructive outlook on valuation.
Anlatı Güncellemesi • Jul 30
CLVT: Fair Value View Will Balance AI Progress Against Prolonged Rebuilding Risks
Clarivate's analyst price target has been revised down from $2.50 to $2.00. Analysts point to the time required for the company to rebuild its foundations and reflect this more cautious view in lower fair value and profit margin assumptions, along with a higher future P/E estimate.Anlatı Güncellemesi • Jul 07
CLVT: Portfolio Sale And AI Investments May Support Future Cash Flow
Clarivate's analyst price target has been adjusted slightly higher to $2.50 from $2.40. Analysts attribute the change to updated views on fair value, future P/E assumptions and profitability as key drivers of the revision.Anlatı Güncellemesi • Jun 22
CLVT: IP Leadership And AI Platforms Will Drive Future Upside
Analysts have kept their $6.00 price target on Clarivate unchanged, citing updated assumptions that now reflect a slightly higher discount rate, modestly adjusted revenue growth and profit margin expectations, and a broadly similar future P/E outlook. What’s in the News for Clarivate Clarivate appointed Simon Webster as President of its Intellectual Property segment, effective June 10, as Maroun S.Anlatı Güncellemesi • Jun 07
CLVT: Fair Value View Balances AI Platform Rollout Against Ongoing Profitability Risks
Analysts have revised their Clarivate price target to $2.40, reflecting updated assumptions about slower revenue declines, lower profit margins, and a higher future P/E of 71.88x in their models. What's in the News Clarivate launched IPOne, a unified IP intelligence platform that uses purpose-built AI agents and proprietary data to support IP research and workflows across enterprises, including activities such as discovery, clearance, prioritization, monitoring, analysis and decision support.Anlatı Güncellemesi • May 23
CLVT: Free Cash Flow May Offset AI And Portfolio Execution Risks
Analysts have trimmed Clarivate price targets into a roughly $2.40 to $6 range, citing concerns around AI-related disruption risks and execution questions on the planned Life Sciences and Healthcare unit sale, even as some highlight solid free cash flow performance and guidance. Analyst Commentary Recent research notes reflect a mixed but generally cautious stance on Clarivate, with most firms trimming price targets while keeping ratings unchanged.Seeking Alpha • May 13
Clarivate: Business Showed Signs Of Stabilization, But It Is Not Enough
Summary Clarivate delivered improved Q1 2026 results, with organic growth turning positive at 0.6% and margin expansion, but reported revenue still declined year over year. Segment trends stabilized, notably with Academia & Government and Life Sciences & Healthcare returning to growth, though IPPG remained a drag at -1.3% organic growth. AI-driven product enhancements and the Value Creation Plan could accelerate organic growth, but sustained improvement is needed before a re-rating is justified. I maintain a hold rating, seeking several more quarters of cleaner execution and stronger IPPG performance before turning more constructive. Read the full article on Seeking AlphaAnlatı Güncellemesi • May 06
CLVT: Life Sciences Sale Execution Will Drive Upside Despite AI Risk
Analysts have trimmed their price expectations for Clarivate, with new targets ranging roughly from $2.40 to $6.00. They cited concerns around AI-related disruption risks and execution on the planned Life Sciences and Healthcare asset sale.Anlatı Güncellemesi • Apr 21
CLVT: Free Cash Flow And Portfolio Simplification May Support Future Upside Potential
The Analyst Price Target for Clarivate has been reduced by about $1, with analysts pointing to AI disintermediation risk and uncertainty around the planned Life Sciences and Healthcare unit sale as key reasons for the reset. Analyst Commentary Recent research points to a more cautious stance on Clarivate, with several banks trimming price targets while keeping a range of ratings from Underweight to Buy.Anlatı Güncellemesi • Apr 07
CLVT: Fair Value View Weighs AI Disruption Against Portfolio Reshaping Risks
Analyst price targets on Clarivate have reset sharply lower into a $2.40 to $6 range, with cuts of up to about $2 to $2.60 as analysts factor in AI disruption risks and uncertainty around the planned Life Sciences and Healthcare segment sale. Analyst Commentary Recent research updates on Clarivate highlight a cautious tilt, with several bearish analysts resetting expectations lower despite references to solid free cash flow metrics and outlined growth targets.Anlatı Güncellemesi • Mar 24
CLVT: Fair Value View Balances AI Competition With Portfolio Execution Risks
Clarivate's analyst price targets have moved lower toward a new implied fair value near $2.40 per share, as analysts factor in slower revenue growth assumptions, lower profit margin expectations, AI related competitive risks, and execution risk around the planned Life Sciences and Healthcare unit sale. Analyst Commentary Recent Street research on Clarivate has tilted more cautious, with several bearish analysts cutting price targets and, in one case, downgrading the stock.Anlatı Güncellemesi • Mar 10
CLVT: Value Creation Plan Execution Will Drive Upside Despite AI Headwinds
Our analyst price target for Clarivate has moved down from $7.00 to $6.00 as analysts trim their targets across the Street. They cite AI related competitive pressures, the execution risk around a potential Life Sciences and Healthcare sale, and a longer timeline for the company’s Value Creation Plan to play out.Anlatı Güncellemesi • Feb 24
CLVT: Extended Plan Execution Will Unlock Value Despite Rising AI Competition
Analysts have trimmed their $4.20 price target on Clarivate to $3.60, reflecting concerns that rising competition from AI-focused rivals, limits on pricing power, and a longer timeline for the company's "Value Creation Plan" temper expectations for organic revenue growth and profitability. Analyst Commentary Goldman Sachs cut its rating on Clarivate to Neutral from Buy and reduced its price target to $3.60 from $4.20, signaling a more cautious stance on the shares.Anlatı Güncellemesi • Feb 09
CLVT: Extended Value Creation Plan Timeline May Support Future Upside Potential
Analysts have trimmed their price target on Clarivate to about US$3.60 from roughly US$4.20, citing a longer timeline for the company's "Value Creation Plan" to influence organic revenue growth, as well as concerns about pressure from AI driven competitors and limited pricing power. Analyst Commentary Bullish Takeaways Bullish analysts still see some value support around the revised US$3.60 target, suggesting expectations have been reset to reflect slower organic growth execution.Analiz Makalesi • Feb 04
Clarivate Plc's (NYSE:CLVT) 35% Dip In Price Shows Sentiment Is Matching Revenues
Clarivate Plc ( NYSE:CLVT ) shareholders that were waiting for something to happen have been dealt a blow with a 35...Anlatı Güncellemesi • Jan 25
CLVT: Extended Plan And AI Competition Will Shape Long-Term Execution Outlook
Analysts have trimmed their price target on Clarivate to $3.60 from $4.20, citing expectations for a longer timeline for the Value Creation Plan to influence organic revenue growth, as well as concerns around competition from AI focused peers and limited pricing power. Analyst Commentary Recent Street research reflects a more cautious stance on Clarivate, with at least one major firm reducing its rating and target price as expectations temper around execution of the Value Creation Plan and the pace of organic revenue growth.Anlatı Güncellemesi • Jan 09
CLVT: Extended Value Creation Timeline Will Confront Intensifying AI Competition
Analysts have trimmed their fair value estimate for Clarivate from US$3.75 to US$3.00, citing a lower Street price target and expectations that the company’s "Value Creation Plan" and efforts to improve organic revenue growth may take longer to show results in the face of rising AI driven competition and limited pricing power. Analyst Commentary Recent Street commentary has turned more cautious on Clarivate, with some price targets cut and ratings pulled back as expectations around the "Value Creation Plan" are reset to a longer timetable.Anlatı Güncellemesi • Dec 22
CLVT: Share Repurchases Will Support Future Earnings Upside
Analysts have trimmed their price target on Clarivate by approximately $0.25. This reflects slightly higher perceived risk via a modestly increased discount rate and a lower future earnings multiple, while leaving their long term growth and profitability assumptions essentially unchanged.Anlatı Güncellemesi • Dec 08
CLVT: Share Buybacks And Raised Guidance Will Support Future Performance
Analysts have slightly lowered their price target on Clarivate to reflect modestly reduced discount rate assumptions and a marginally lower future price-to-earnings multiple, while keeping their fair value estimate effectively unchanged at approximately $4.93 per share. What's in the News Clarivate completed a share repurchase of 34,823,885 shares, representing 5.11% of outstanding shares, for a total of $149.47 million under its December 16, 2024 buyback authorization (Key Developments).Anlatı Güncellemesi • Nov 24
CLVT: Strong Market Share Will Support Future Performance Despite AI Risk
Analysts have slightly raised their price target for Clarivate to nearly $5 per share. They cite the firm’s solid market position but note ongoing risks from budget constraints, AI competition, and leverage concerns.Anlatı Güncellemesi • Nov 09
CLVT: Market Position And AI Developments Will Drive Performance Ahead
Analysts have lowered Clarivate's price target from approximately $5.14 to $4.93 per share. They cite concerns over budget constraints in key sectors, potential risks from artificial intelligence, and the company’s elevated leverage, despite its strong market position.Analiz Makalesi • Sep 16
These 4 Measures Indicate That Clarivate (NYSE:CLVT) Is Using Debt Extensively
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analiz Makalesi • Aug 02
Earnings Update: Clarivate Plc (NYSE:CLVT) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
One of the biggest stories of last week was how Clarivate Plc ( NYSE:CLVT ) shares plunged 20% in the week since its...Analiz Makalesi • Jul 26
Is There An Opportunity With Clarivate Plc's (NYSE:CLVT) 32% Undervaluation?
Key Insights Clarivate's estimated fair value is US$6.63 based on 2 Stage Free Cash Flow to Equity Clarivate's US$4.53...Analiz Makalesi • Jul 08
At US$4.40, Is Clarivate Plc (NYSE:CLVT) Worth Looking At Closely?
While Clarivate Plc ( NYSE:CLVT ) might not have the largest market cap around , it led the NYSE gainers with a...Yeni Anlatı • May 11
Subscription Model And AI Integration Will Drive Operational Efficiency
Transitioning to a subscription-based model and AI innovation enhances revenue stability and competitive edge, supporting growth and improving net margins.Analiz Makalesi • May 04
Optimistic Investors Push Clarivate Plc (NYSE:CLVT) Shares Up 27% But Growth Is Lacking
Clarivate Plc ( NYSE:CLVT ) shareholders are no doubt pleased to see that the share price has bounced 27% in the last...Analiz Makalesi • Apr 23
Clarivate Plc (NYSE:CLVT) Shares Could Be 33% Below Their Intrinsic Value Estimate
Key Insights Clarivate's estimated fair value is US$4.92 based on 2 Stage Free Cash Flow to Equity Current share price...Analiz Makalesi • Apr 08
Should You Investigate Clarivate Plc (NYSE:CLVT) At US$3.37?
Clarivate Plc ( NYSE:CLVT ), is not the largest company out there, but it saw significant share price movement during...Gelir ve Gider Dağılımı
Gelir ve Gider Dağılımı
Clarivate nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 26 | 2,413 | -334 | 707 | 0 |
| 31 Mar 26 | 2,447 | -137 | 707 | 0 |
| 31 Dec 25 | 2,455 | -201 | 709 | 0 |
| 30 Sep 25 | 2,501 | -396 | 710 | 0 |
| 30 Jun 25 | 2,500 | -433 | 710 | 0 |
| 31 Mar 25 | 2,529 | -678 | 714 | 0 |
| 31 Dec 24 | 2,557 | -668 | 728 | 0 |
| 30 Sep 24 | 2,577 | -1,339 | 732 | 0 |
| 30 Jun 24 | 2,602 | -1,280 | 732 | 0 |
| 31 Mar 24 | 2,621 | -1,105 | 739 | 0 |
| 31 Dec 23 | 2,629 | -987 | 740 | 0 |
| 30 Sep 23 | 2,620 | 181 | 735 | 0 |
| 30 Jun 23 | 2,609 | -4,247 | 735 | 0 |
| 31 Mar 23 | 2,627 | -4,062 | 729 | 0 |
| 31 Dec 22 | 2,660 | -4,036 | 730 | 0 |
| 30 Sep 22 | 2,545 | -4,470 | 734 | 0 |
| 30 Jun 22 | 2,352 | -30 | 709 | 0 |
| 31 Mar 22 | 2,111 | -205 | 702 | 0 |
| 31 Dec 21 | 1,877 | -312 | 643 | 0 |
| 30 Sep 21 | 1,772 | -195 | 635 | 0 |
| 30 Jun 21 | 1,614 | -383 | 622 | 0 |
| 31 Mar 21 | 1,442 | -277 | 546 | 0 |
| 31 Dec 20 | 1,254 | -351 | 545 | 0 |
| 30 Sep 20 | 1,053 | -469 | 516 | 0 |
| 30 Jun 20 | 1,012 | -277 | 490 | 0 |
| 31 Mar 20 | 981 | -329 | 513 | 0 |
| 31 Dec 19 | 974 | -259 | 475 | 0 |
| 30 Sep 19 | 965 | -170 | 419 | 0 |
| 30 Jun 19 | 964 | -235 | 410 | 0 |
| 31 Mar 19 | 965 | -224 | 379 | 0 |
| 31 Dec 18 | 968 | -242 | 413 | 0 |
| 31 Dec 17 | 918 | -264 | 361 | 0 |
Kaliteli Kazançlar: CLVT şu anda kârlı değil.
Büyüyen Kar Marjı: CLVT şu anda kârlı değil.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: CLVT kârlı değildir, ancak son 5 yılda zararlarını yılda 18.4% oranında azaltmıştır.
Büyüme Hızlandırma: CLVT 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil
Kazançlar vs. Sektör: CLVT kârlı olmadığından, geçmiş yıl kazanç büyümesinin Professional Services sektörüyle ( 8.1% ) karşılaştırılması zorlaşıyor.
Özkaynak Getirisi
Yüksek ROE: CLVT hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -7.36% ) sahiptir.
Varlık Getirisi
Kullanılan Sermaye Getirisi
Geçmişte güçlü performans gösteren şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/09/15 04:29 |
| Gün Sonu Hisse Fiyatı | 2026/09/15 00:00 |
| Kazançlar | 2026/06/30 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Clarivate Plc 13 Bu analistlerden 1, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Manav Patnaik | Barclays |
| Heather Balsky | BofA Global Research |
| Zachary Cummins | B. Riley Securities, Inc. |